CELL BIOLOGY • CELL CYCLE, DIVISION, AND CELL DEATH

Cell Cycle Phases & Checkpoints — Describe cell cycle phases (G1, S, G2, M) and checkpoints

Understanding how eukaryotic cells faithfully replicate their genome, grow, and divide under strict regulatory surveillance.

Historical Context & Motivation

The concept of the cell cycle — the ordered sequence of events by which a cell duplicates its contents and divides — arose from a convergence of microscopy, biochemistry, and genetics over more than a century of investigation. Early microscopists in the nineteenth century observed mitotic figures in dividing tissues, yet they could not explain what governed the timing or fidelity of division. The question that drove researchers was deceptively simple: how does a cell know when to divide, and what prevents it from dividing at the wrong time?

The discovery that cells progress through discrete phases — rather than continuously growing and splitting — fundamentally reshaped our understanding of proliferation and laid the groundwork for modern cancer biology, developmental biology, and regenerative medicine. Each key milestone in this history revealed another layer of regulatory sophistication, ultimately culminating in the identification of cyclins and cyclin-dependent kinases (CDKs) as the master oscillators of cell division.

1882
Walther Flemming Describes Mitosis
Using improved aniline dyes, Flemming documented the behavior of chromatin during cell division in salamander larvae, coining the term "mitosis" and establishing cytology as a rigorous discipline.
1953
Howard & Pelc Define Cell Cycle Phases
Alma Howard and Stephen Pelc used ³²P autoradiography in Vicia faba root tips to demonstrate that DNA synthesis occurs during a discrete S phase, flanked by two gap phases (G1 and G2), formalizing the four-phase model.
1970
Rao & Johnson's Cell Fusion Experiments
By fusing cells in different phases, Potu Rao and Robert Johnson demonstrated that cytoplasmic factors could drive nuclei into S phase or mitosis, providing early evidence for diffusible cell cycle regulators.
1982–1983
Discovery of Cyclins
Tim Hunt identified proteins in sea urchin eggs that oscillated in abundance with each division — he named them cyclins. Concurrently, Leland Hartwell and Paul Nurse identified CDK genes in yeast (CDC28 and cdc2), linking kinase activity to phase transitions.
2001
Nobel Prize in Physiology or Medicine
Hartwell, Hunt, and Nurse shared the Nobel Prize for discoveries of key regulators of the cell cycle, cementing the cyclin-CDK paradigm and the concept of checkpoints as surveillance mechanisms ensuring genomic integrity.

The central question these discoveries addressed remains at the heart of cell biology today: how does a cell coordinate DNA replication, organelle duplication, and cytokinesis in a manner that preserves genomic integrity across billions of divisions in a multicellular organism? The answer lies in the precise temporal regulation of the cell cycle phases and the checkpoint mechanisms that monitor each critical transition.

Core Principles & Definitions

The eukaryotic cell cycle is divided into two major periods: interphase, during which the cell grows and replicates its DNA, and the mitotic (M) phase, during which the duplicated chromosomes are segregated and the cell physically divides. Interphase is further subdivided into G1, S, and G2, giving rise to the canonical four-phase model. Superimposed on this cycle are checkpoints — biochemical surveillance mechanisms that halt progression if specific conditions are not met, ensuring that each phase is completed accurately before the next one begins.

1

G1 Phase (First Gap)

The cell grows in size, synthesizes proteins and organelles, and integrates mitogenic and anti-mitogenic signals. Passage through the restriction point (R) commits the cell to division, rendering it independent of external growth factor signaling.
2

S Phase (Synthesis)

The cell replicates its entire nuclear genome exactly once, producing two sister chromatids per chromosome joined at their centromeres. The centrosome also duplicates during S phase, preparing the mitotic spindle apparatus.
3

G2 Phase (Second Gap)

The cell continues to grow and synthesize proteins required for mitosis, such as tubulin. DNA repair pathways resolve any replication errors before the cell commits to chromosome condensation and segregation.
4

M Phase (Mitosis & Cytokinesis)

Nuclear division (mitosis) proceeds through prophase, prometaphase, metaphase, anaphase, and telophase, followed by cytokinesis — the physical cleavage of the cytoplasm. The result is two genetically identical daughter cells.
5

Checkpoints

Three principal checkpoints — the G1/S checkpoint, the G2/M checkpoint, and the spindle assembly checkpoint (SAC) — verify DNA integrity, replication completeness, and proper chromosome attachment, respectively. Failure of checkpoint enforcement is a hallmark of cancer.
KEY TAKEAWAY
Think of the cell cycle as an assembly-line quality control system in a semiconductor fabrication plant. Each workstation (G1, S, G2, M) performs a specific manufacturing step, and between stations sit quality inspectors (checkpoints) who halt the line if a defect is detected. Just as shipping a flawed chip could cascade into system failures, allowing a cell with damaged DNA to divide can propagate mutations that lead to cancer. The checkpoints exist not merely to verify completion of each phase but to enforce an all-or-nothing commitment: proceed correctly or stop entirely.

Visual Overview of the Cell Cycle

The circular diagram represents the four phases of the cell cycle: G1 (blue), S (violet), G2 (cyan), and M (pink). Red circles mark the three major checkpoints (G1/S, G2/M, and SAC), while the gold circle denotes the restriction point (R). Cells may exit into G₀ quiescence from G1.

As illustrated in the diagram above, the cell cycle is conventionally depicted as a circular pathway emphasizing its repetitive nature. The three interphase stages (G1, S, and G2) collectively occupy the majority of total cycle time — typically 90% or more in mammalian somatic cells. The M phase, though visually dramatic, is comparatively brief. Notice that the restriction point sits within G1, functioning as a molecular switch: before R, the cell requires mitogenic signals (growth factors) to proceed; after R, progression through S, G2, and M becomes autonomous and driven by internal cyclin-CDK oscillations. Cells that do not receive adequate mitogenic stimulation may exit into G₀, a quiescent state from which they can re-enter the cycle upon appropriate signaling — or remain indefinitely, as is the case for terminally differentiated neurons.

Molecular Mechanisms of Cell Cycle Control

Progression through the cell cycle is driven by the sequential activation and inactivation of cyclin-dependent kinases (CDKs) — serine/threonine protein kinases whose catalytic activity depends on binding a regulatory cyclin subunit. While CDK protein levels remain relatively constant throughout the cycle, cyclin concentrations oscillate dramatically, rising through transcriptional activation and falling through ubiquitin-mediated proteolysis. This oscillatory behavior produces distinct waves of CDK activity that phosphorylate stage-specific substrates, triggering the transitions between phases.

The Cyclin-CDK Engine

Major cyclin-CDK complexes and their roles during the cell cycle
Cell Cycle PhaseCyclin PartnerCDK PartnerKey Substrates / Function
G1 (early)Cyclin DCDK4, CDK6Phosphorylates Rb, releasing E2F transcription factors to activate S-phase gene expression
G1/S transitionCyclin ECDK2Hyperphosphorylates Rb, activates pre-replication complexes, passes restriction point
S phaseCyclin ACDK2Fires replication origins, prevents re-replication by phosphorylating licensing factors
G2/M transitionCyclin A, Cyclin BCDK1 (Cdc2)Triggers chromosome condensation, nuclear envelope breakdown, spindle assembly
M phase exitCyclin B (degraded)CDK1 (inactivated)APC/C-mediated cyclin B destruction drives mitotic exit and cytokinesis

Checkpoint Signaling Cascades

Checkpoints rely on sensor kinases that detect DNA damage or incomplete replication and relay signals to effector kinases that arrest the cycle. At the G1/S checkpoint, DNA double-strand breaks activate ATM (ataxia-telangiectasia mutated), which phosphorylates Chk2 and p53. Stabilized p53 induces transcription of the CDK inhibitor p21 (a CKI), which binds and inhibits cyclin E-CDK2, preventing S-phase entry. At the G2/M checkpoint, stalled replication forks activate ATR, which phosphorylates Chk1. Chk1 phosphorylates the phosphatase Cdc25, targeting it for cytoplasmic sequestration or degradation, thereby preventing removal of inhibitory phosphorylation on CDK1 and blocking mitotic entry.

The spindle assembly checkpoint (SAC) operates by a distinct mechanism. Unattached or improperly attached kinetochores generate a diffusible "wait" signal composed of the mitotic checkpoint complex (MCC), which includes Mad2, BubR1, Bub3, and Cdc20. The MCC sequesters Cdc20 and thus prevents activation of the anaphase-promoting complex/cyclosome (APC/C). Only when every kinetochore achieves stable, bipolar microtubule attachment does MCC disassemble, freeing Cdc20 to activate APC/C. APC/C then ubiquitinates securin (releasing separase to cleave cohesin) and cyclin B, driving anaphase onset and mitotic exit.

⚕️ Clinical Connection
Loss-of-function mutations in p53 (the TP53 gene) eliminate the G1/S checkpoint and are found in over 50% of human cancers. Similarly, overexpression of Cyclin D1 or loss of the CKI p16INK4a deregulates G1 progression and is a hallmark of many tumor types. Understanding checkpoint biology has directly informed the development of targeted cancer therapeutics such as CDK4/6 inhibitors (e.g., palbociclib) and Chk1 inhibitors.

Detailed Phase-by-Phase Breakdown

Although the conceptual overview of the four cell cycle phases is straightforward, each phase involves a complex choreography of molecular events. The following detailed breakdown examines the key processes, durations, and regulatory features of each phase in a typical rapidly proliferating mammalian cell with a cycle time of approximately 24 hours.

A linear timeline representation of the cell cycle showing the approximate duration of each phase in a typical 24-hour mammalian cell cycle. Key molecular events are listed for each phase, and checkpoint locations are indicated at the bottom. Note that G1 is the most variable phase — its length is the primary determinant of overall cycle time.

G1: The Decision Phase

G1 is the most variable phase in terms of duration and is the period during which the cell integrates proliferative and anti-proliferative signals to decide its fate. Growth factors binding to receptor tyrosine kinases activate downstream cascades — most notably the Ras → Raf → MEK → ERK (MAPK) pathway — that induce expression of Cyclin D. Cyclin D-CDK4/6 complexes mono-phosphorylate the retinoblastoma protein (Rb), partially relieving its repression of E2F transcription factors. This positive-feedback loop culminates at the restriction point, after which Cyclin E-CDK2 hyper-phosphorylates Rb, fully activating E2F-dependent transcription of S-phase genes. Critically, pre-replication complexes (pre-RCs) are assembled at origins of replication during G1 — a process termed licensing — but they are not yet fired. This temporal separation of licensing (G1) from firing (S) is essential to ensure each origin fires only once per cycle.

S Phase: Genome Duplication

During S phase, Cyclin A-CDK2 and DDK (Dbf4-dependent kinase) phosphorylate components of the pre-RC to initiate bidirectional replication from thousands of origins distributed across the genome. Replication proceeds with remarkable fidelity — the error rate of replicative DNA polymerases, coupled with proofreading, is approximately 10⁻⁷ per nucleotide per cell division — but the sheer scale of replicating ~6.4 × 10⁹ base pairs in the human diploid genome means that occasional errors are inevitable. Concurrently, the cell synthesizes new histones (primarily during S phase) and assembles them onto daughter strands via histone chaperones such as CAF-1. A crucial safety feature is the intra-S checkpoint: if replication forks stall (e.g., due to DNA lesions), ATR-Chk1 signaling suppresses firing of late origins and stabilizes stalled forks, preventing fork collapse and chromosomal breakage.

G2: The Preparation Phase

G2 serves as a final preparation period before mitosis. The cell continues to grow and synthesizes mitosis-specific proteins, including Cyclin B, which accumulates in the cytoplasm in an inactive complex with CDK1 held in check by inhibitory phosphorylation at Thr14 and Tyr15 (mediated by Wee1 and Myt1 kinases). The G2/M checkpoint evaluates whether replication is complete and DNA integrity is maintained. If unreplicated regions or DNA damage persist, ATR/ATM → Chk1/Chk2 pathways inactivate the Cdc25 phosphatases that would otherwise remove the inhibitory phosphorylation on CDK1, effectively blocking mitotic entry. Only when the genome passes this quality-control assessment does Cdc25 activate CDK1, generating the burst of kinase activity that triggers prophase.

M Phase: Division

Mitosis proceeds through five morphologically defined stages. In prophase, condensin complexes compact chromatin into discrete chromosomes and the mitotic spindle begins to form from the duplicated centrosomes. Prometaphase begins with nuclear envelope breakdown (NEBD), driven by CDK1 phosphorylation of nuclear lamins, allowing spindle microtubules to capture kinetochores. During metaphase, all chromosomes achieve bipolar attachment and congress to the metaphase plate. The SAC monitors this process and only silences when every kinetochore is properly attached and under tension. Anaphase begins with APC/C-mediated degradation of securin, freeing separase to cleave cohesin, and degradation of Cyclin B, which inactivates CDK1. Sister chromatids are pulled to opposite poles. In telophase, nuclear envelopes reform around decondensing chromosomes, and cytokinesis physically divides the cell by contraction of the actomyosin contractile ring at the cleavage furrow, yielding two genetically identical daughter cells.

Worked Example: Analyzing Cell Cycle Regulation

Consider the following experimental scenario, which integrates cell cycle phase identification, checkpoint function, and molecular regulation — the type of problem commonly encountered on cell biology examinations.

Predicting Checkpoint Responses to DNA Damage
1
Step 1 — Read the ProblemA population of cultured HeLa cells is irradiated with UV light, which produces pyrimidine dimers in DNA. Flow cytometry reveals that cells accumulate with both 2N and 4N DNA content, but very few cells are observed in mitosis. A subset of cells are then treated with caffeine (a known inhibitor of ATM and ATR kinases). After caffeine treatment, cells with 4N DNA content are observed entering mitosis despite the presence of unrepaired damage. Explain these observations using your knowledge of cell cycle checkpoints.
2
Step 2 — Identify the Phase DistributionFlow cytometry measures DNA content per cell. Cells with 2N content are in G1 (or early S), cells between 2N and 4N are in S phase, and cells with 4N content are in G2 or M. The observation of accumulation at 2N and 4N indicates that cells are arresting at two checkpoints: the G1/S checkpoint (2N arrest) and the G2/M checkpoint (4N arrest).
Cell arrest occurs at both G1/S (2N) and G2/M (4N) checkpoints
3
Step 3 — Explain the Molecular Basis of ArrestUV-induced pyrimidine dimers are detected by the DNA damage response. At the G1/S boundary, the ATR pathway activates Chk1, which stabilizes p53, leading to transcription of p21. p21 inhibits Cyclin E-CDK2, preventing S-phase entry. At the G2/M boundary, ATR → Chk1 phosphorylates Cdc25, preventing activation of Cyclin B-CDK1, blocking mitotic entry. The very few mitotic cells observed are consistent with potent checkpoint enforcement.
ATR → Chk1 → p53/p21 arrests G1/S; ATR → Chk1 → Cdc25 inhibition arrests G2/M
4
Step 4 — Explain the Effect of CaffeineCaffeine inhibits ATM and ATR, the apical sensor kinases of the DNA damage checkpoint pathway. Without ATR activity, Chk1 is not phosphorylated, and therefore Cdc25 remains active. Active Cdc25 removes inhibitory phosphorylation from CDK1, allowing Cyclin B-CDK1 to drive cells with 4N DNA content (i.e., cells in G2) into mitosis. This is called checkpoint override — the cells enter mitosis with unrepaired DNA damage, which frequently leads to mitotic catastrophe and cell death.
Caffeine overrides the G2/M checkpoint by inhibiting ATR/ATM, permitting premature mitotic entry with damaged DNA
5
Step 5 — Clinical SignificanceNote that HeLa cells harbor inactivated p53 (due to HPV E6-mediated degradation), so their G1/S checkpoint is already compromised. The 2N accumulation observed is likely due to residual p53-independent mechanisms. The caffeine experiment demonstrates a principle exploited in cancer therapy: tumor cells with defective G1 checkpoints depend heavily on the G2/M checkpoint for survival after DNA damage. Inhibiting this remaining checkpoint ("synthetic lethality") selectively kills cancer cells while sparing normal cells with intact G1 checkpoints.
Checkpoint override in p53-deficient cells is the basis for synthetic lethal therapeutic strategies targeting the G2/M checkpoint in cancer

Checkpoint Strengths, Limitations & Cancer Relevance

The checkpoint system is remarkably robust under normal physiological conditions, yet it is not infallible. Understanding both the strengths and vulnerabilities of cell cycle checkpoints is essential for appreciating how their failure contributes to oncogenesis and how their exploitation informs cancer therapy.

Comparison of cell cycle checkpoint strengths and vulnerabilities
CheckpointStrengthsVulnerabilities / Limitations
G1/S (Restriction Point)Integrates multiple signals (growth factors, nutrients, cell size, DNA integrity); provides irreversible commitment via positive feedback; p53 pathway can trigger apoptosis if damage is severeDependent on functional p53 — loss of p53 eliminates this checkpoint in over half of all human cancers; Rb inactivation (e.g., by HPV E7) bypasses the restriction point entirely
Intra-S CheckpointStabilizes stalled replication forks; suppresses late origin firing to reduce collision risk; coordinates repair with ongoing replicationCannot detect all lesion types equally; some adducts are tolerated and may be bypassed by translesion synthesis polymerases, introducing mutations
G2/MLast DNA quality checkpoint before mitosis; allows time for homologous recombination repair of double-strand breaks; amplifies signal via CDK1 inhibitionCan be overridden by oncogenic signaling (e.g., Plk1 or Cdc25 overexpression); checkpoint adaptation can occur in some organisms, allowing eventual mitotic entry despite damage
Spindle Assembly Checkpoint (SAC)Exquisitely sensitive — a single unattached kinetochore can delay anaphase; prevents aneuploidy by ensuring bipolar attachment of all chromosomesMerotelic attachments (one kinetochore to both poles) can evade detection; weakened SAC (e.g., reduced BubR1) causes chromosomal instability (CIN), a hallmark of many solid tumors
KEY TAKEAWAY
Checkpoints function like a multi-tiered security system in a nuclear facility: redundant sensors, escalating responses (delay → repair → apoptosis), and fail-safes at every transition. However, just as a security system is only as strong as its weakest component, loss of even a single checkpoint element — such as p53 — can allow a "breach" that permits damaged cells to proliferate. Cancer, in this analogy, is essentially a security failure at one or more checkpoints, allowing cells with accumulated mutations to evade the safeguards that normally enforce genomic integrity.

Connections to Advanced Topics

The cell cycle model presented in this lesson describes the canonical mitotic cell cycle of proliferating somatic cells. However, this framework connects to several advanced and specialized topics that extend or modify the basic paradigm. Understanding these connections provides important context for upper-division coursework in developmental biology, stem cell biology, and cancer genomics.

Connections between cell cycle fundamentals and advanced biological topics
Concept in This LessonAdvanced ExtensionKey Differences / Additions
G1/S restriction pointMeiotic commitmentIn meiosis, pre-meiotic S phase is followed by two successive divisions (meiosis I and II) without an intervening S phase; unique regulation by meiosis-specific cyclins and the synaptonemal complex
G₀ quiescenceSenescence & terminal differentiationSenescent cells exit the cycle irreversibly via p16-Rb locking and acquire the senescence-associated secretory phenotype (SASP); distinct from quiescence, which is reversible
Cyclin-CDK oscillationEndoreplication & polyploidySome specialized cells (hepatocytes, megakaryocytes, trophoblast giant cells) undergo S phase without mitosis, driven by oscillation of S-phase CDK activity while suppressing mitotic CDK activity
Checkpoint-mediated arrestApoptosis & mitotic catastropheWhen damage is irreparable, checkpoints can trigger apoptosis (via p53 → Bax/Bak → cytochrome c) or, if cells enter mitosis with damage, mitotic catastrophe — a form of cell death involving aberrant mitosis
SAC and chromosome segregationChromosomal instability (CIN) in cancerWeakened SAC leads to whole-chromosome gains/losses (aneuploidy) that can fuel tumor evolution through karyotypic heterogeneity; a driver of intratumoral diversity and drug resistance

As you continue in cell biology, you will encounter these extensions in greater depth. The unifying theme is that the core cyclin-CDK oscillator and checkpoint framework you have learned here provides the regulatory foundation upon which all variations — meiotic, endoreplicative, apoptotic — are built. Mastery of the standard mitotic cell cycle is therefore prerequisite to understanding virtually every aspect of cellular proliferation, differentiation, and death in eukaryotic organisms.

Practice Problems

PROBLEM 1CONCEPTUAL
A researcher treats cells with a drug that prevents all phosphorylation of the retinoblastoma protein (Rb). Predict which cell cycle phase the cells will arrest in and explain why, referencing the specific cyclin-CDK complexes and transcription factors involved.
PROBLEM 2BASIC CALCULATION
In a population of asynchronously dividing cells with a total cell cycle time of 20 hours, you determine by flow cytometry that 60% of cells have 2N DNA content, 25% have between 2N and 4N, and 15% have 4N content. Estimate the duration of G1, S phase, and (G2 + M) in hours, assuming the fraction of cells in each phase is proportional to the fraction of total cycle time spent in that phase.
PROBLEM 3INTERMEDIATE
You perform a cell fusion experiment (similar to Rao and Johnson, 1970). You fuse a cell in S phase with a cell in G1. You also fuse a cell in M phase with a cell in G1. Predict the outcome for the G1 nucleus in each scenario and explain the molecular basis, identifying the specific cytoplasmic factors responsible.
PROBLEM 4APPLIED
A pharmaceutical company is developing a new anti-cancer drug that specifically inhibits the Cdc25A phosphatase. Predict: (a) At which cell cycle transition will cells arrest? (b) What will be the phosphorylation state of CDK2 in treated cells? (c) Why might this drug be more effective against rapidly dividing tumor cells than slowly dividing normal cells? (d) Propose one potential side effect based on the drug's mechanism.
PROBLEM 5CRITICAL THINKING
The spindle assembly checkpoint (SAC) can delay anaphase for hours when even a single kinetochore is unattached. However, merotelic attachments (where a single kinetochore is attached to microtubules from both spindle poles) are typically not detected by the SAC. (a) Explain why the SAC fails to detect merotelic attachments based on its molecular mechanism. (b) What is the likely chromosomal consequence of an undetected merotelic attachment? (c) How does the cell normally correct merotelic attachments before anaphase, and what enzyme is primarily responsible? (d) Discuss why complete abolition of the SAC is lethal, whereas partial weakening of the SAC can promote tumorigenesis.

Summary

The eukaryotic cell cycle consists of four ordered phases: G1 (growth and signal integration), S phase (DNA replication), G2 (preparation for mitosis), and M phase (chromosome segregation and cytokinesis). Progression is driven by the oscillating activity of cyclin-CDK complexes: Cyclin D-CDK4/6 and Cyclin E-CDK2 govern the G1/S transition, Cyclin A-CDK2 drives S phase, and Cyclin B-CDK1 triggers mitotic entry. The restriction point in late G1 marks the irreversible commitment to division, after which the cell proceeds independently of mitogenic signaling. Cells that do not receive sufficient proliferative signals may exit into G₀ quiescence.

Superimposed on this oscillator are three principal checkpoints that enforce genomic integrity. The G1/S checkpoint utilizes the ATM/ATR → Chk1/Chk2 → p53 → p21 pathway to block S-phase entry when DNA is damaged. The G2/M checkpoint prevents mitotic entry by inhibiting Cdc25 phosphatases and thereby maintaining CDK1 in its inactive, phosphorylated state. The spindle assembly checkpoint (SAC) delays anaphase until all kinetochores achieve stable bipolar microtubule attachment, acting through the mitotic checkpoint complex (MCC) to inhibit APC/C. Failure of these checkpoints — through mutations in p53, Rb, or SAC components — is a hallmark of cancer, and pharmacological exploitation of checkpoint dependencies is a major frontier in targeted cancer therapy.

Varsity Tutors • Cell Biology • Cell Cycle Phases & Checkpoints